Eptacog beta at a dose level of 225 µg/kg is safe and tolerable in patients with hemophilia A and B, according to a clinical trial analysis published in Haemophilia.
Eptacog beta, an activated recombinant human factor VII bypassing agent, was FDA…
Eptacog beta at a dose level of 225 µg/kg is safe and tolerable in patients with hemophilia A and B, according to a clinical trial analysis published in Haemophilia.
Eptacog beta, an activated recombinant human factor VII bypassing agent, was FDA…